Extracts of Momordica charantia suppress postprandial hyperglycemia in rats

Journal of Nutritional Science and Vitaminology

Volumn 53, Issue 6, 2007, Pages 482-488

  Uebanso, Takashi ^a   Arai, Hidekazu ^a,c   Taketani, Yutaka ^a   Fukaya, Makiko ^a   Yamamoto, Hironori ^a   Mizuno, Akira ^a   Uryu, Keisuke ^b   Hada, Takahiko ^b   Takeda, Eiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Bizen Chemical Co Ltd   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

glucosidase inhibitor; Momordica charantia; Postprandial hyperglycemia

Indexed keywords

ALPHA GLUCOSIDASE; METHANOL FRACTION; METHANOL INSOLUBLE FRACTION; MOMORDICA CHARANTIA EXTRACT; SUCRASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVITY; HYPERGLYCEMIA; INTESTINE MUCOSA; MOLECULAR WEIGHT; MOMORDICA CHARANTIA; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; RAT;

ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; ENZYME INHIBITORS; HYPERGLYCEMIA; INSULIN; MALE; MOMORDICA CHARANTIA; PLANT PREPARATIONS; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; SUCRASE;

CUCUMIS; MOMORDICA CHARANTIA; RATTUS;

EID: 38549084069     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.53.482     Document Type: Article

References (41)

1. Balkau B. 2000. The DECODE Study, Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab 26: 282-286.
2. Ceriello A. 2005. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54: 1-7.
3. Mooradian AD, Thurman JE. 1999. Drug therapy of postprandial hyperglycemia. Drugs 57: 19-29.
4. Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM, Palmason C, Cohen RM, Wolever TM. 1996. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19: 1190-1193.
5. Sudhir R, Mohan V. 2002. Postprandial hyperglycemia in patients with type 2 diabetes mellitus. Treat Endocrinol 1: 105-116.
6. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trail Research Group. 2002. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 359: 2072-2077.
7. Chaturvedi P, George S, Milinganyo M, Tripathi YB. 2004. Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res 18: 954-956.
8. Shetty AK, Kumar GS, Sambaiah K, Salimath PV. 2005. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr 60: 109-112.
9. Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH. 1981. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J 282: 1823-1824.
10. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. 1986. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 17: 277-282.
11. Basch E, Gabardi S, Ulbricht C. 2003. Bitter melon (Momordica charantia): A review of efficacy and safety. Am J Health Syst Pharm 60: 356-359.
12. Virdi J, Sivakami S, Suthar AC, Banavalikar MM, Biyani MK. 2003. Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol 88: 107-111.
13. Yibchok-Anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH. 2006. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull 29: 1126-1131.
14. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I. 2001. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol 47: 340-344.
15. Miura T, Itoh Y, Iwamoto N, Kato M, Ishida T. 2004. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol Pharm Bull 27: 248-250.
16. Chen Q, Chan LL, Li ET. 2003. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose torelance in rats fed a high fat diet. J Nutr 133: 1088-1093.
17. Daly ME, Vale C, Walker M, Littlefield A, Alberti KG, Mathers JC. 1998. Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr 67: 1186-1196.
18. Mizuno A, Murakami T, Otani S, Kuwajima M, Shima K. 1998. Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 139: 3863-3870.
19. Arai H, Mizuno A, Matsuo K, Fukaya M, Sasaki H, Arima H, Matsuura M, Taketani Y, Doi T, Takeda E. 2004. Effect of novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 53: 977-983.
20. Dahlqvist A. 1964. Method for assay of intestinal disaccharaidases. Anal Biochem 7: 18-25.
21. Dahlqvist A. 1968. Assay of intestinal disaccharaidases. Anal Biochem 22: 99-107.
22. Matsuura H, Asakawa C, Kurimoto M, Mizutani J. 2002. α-Glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa. Biosci Biotechnol Biochem 66: 1576-1578.
23. Kumar Shetty A, Suresh Kumar G, Veerayya Salimath P. 2005. Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res 49: 791-796.
24. y mice. Life Sci 70: 219-227.
25. Itoh T, Kita N, Kurokawa Y, Kobayashi M, Horio F, Furuichi Y. 2004. Suppressive effect of a hot water extract of adzuki beans (Vigna angularis) on hyperglycemia after sucrose loading in mice and diabetic rats. Biosci Biotechnol Biochem 68: 2421-2426.
26. Fujisawa T, Ikegami H, Inoue K, Kawabata Y, Ogihara T. 2005. Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism 54: 387-390.
27. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP. 2002. Expression of monosaccharide transporters in intestine of diabetic humans. Am J Gastrointest Liver Physiol 282: G241-248.
28. Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J. 2004. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Mol Cell Biochem 261: 63-70.
29. Casirola DM, Ferraris RP. 2006. α-Glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism 55: 832-841.
30. Ali L, Khan AK, Mamun MI, Moshiuzzaman M, Nahar N. Nur-e-Alam M, Rokeya B. 1993. Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats. Planta Med 59: 408-412.
31. Harinantenaina L, Tanaka M, Takaoka S, Oda M, Mogami O, Uchida M. Asakawa Y. 2006. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull 54: 1017-1021.
32. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. 2004. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 27: 2429-2437.
33. Yamamoto M, Jia DM, Fukumitsu KI, Imoto I, Kihara Y, Hirohata Y, Otsuki M. 1999. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by α-glucosidase inhibitor. Metabolism 48: 347-354.
34. Matsui T, Ebuchi S, Fukui K, Matsugano K, Terahara N. Matsumoto K. 2004. Caffeoylsophorose, a new natural α-glucosidas inhibitor, from red vinegar by fermented purple-fleshed sweet potato. Biosci Biotechnol Biochem 68: 2239-2246.
35. Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. 1998. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract 40: 145-151.
36. Quan J, Yin X, Jin M, Shen M. 2003. Study on the inhibition of alpha-glucosidase by soy saponins. Zhong Yao Cai 26: 654-656.
37. Zhang SJ, Qu WJ, Zhong SY. 2006. Inhibitory effects of saponins from Tribulus terrestris on alpha-glucosidase in small intestines of rats. Zhongguo Zhong Yao Za Zhi 31: 910-913.
38. Kim JH, Ryu YB, Kang NS, Lee BW, Heo JS, Jeong IY, Park KH. 2006. Glycosidase inhibitory flavonoids from Sophora flavescens. Biol Pharm Bull 29: 302-305.
39. Anila L, Vijayalakshmi NR. 2000. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 14: 592-595.
40. Grover JK, Yadav SP. 2004. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 93: 123-132.
41. Brennan CS. 2005. Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res 49: 560-570.